PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan. ali.shaukat@duhs.edu.pk.\', \'Dow University Hospital, Dow University of Health Sciences, Karachi, Pakistan.\', \'Dow Research Institute of Biotechnology and Biomedical Sciences, Dow University of Health Sciences, Karachi, Pakistan.\', \'Dow College of Biotechnology, Dow University of Health Sciences, Karachi, Pakistan.\', \'Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan.\', \'National Control Laboratory for Biologicals, Islamabad, Pakistan.\', \'Dow University of Health Sciences, Karachi, Pakistan.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-020-04839-5
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33138867
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33138867>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33138867>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all